170 related articles for article (PubMed ID: 34045609)
1. Overexpression of S100A9 in tumor stroma contribute to immune evasion of NK/T cell lymphoma and predict poor response rate.
Zhou Z; Chen X; Li Z; Wang X; Zhang M
Sci Rep; 2021 May; 11(1):11220. PubMed ID: 34045609
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
[TBL] [Abstract][Full Text] [Related]
3. S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine.
Zhou Z; Li Z; Sun Z; Zhang X; Lu L; Wang Y; Zhang M
Sci Rep; 2016 Mar; 6():23695. PubMed ID: 27021626
[TBL] [Abstract][Full Text] [Related]
4. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
Ma H; Shen L; Yang H; Gong H; Du X; Li J
IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor receptor alpha (PDGFRα) is overexpressed in NK/T-cell lymphoma and mediates cell survival.
Lu L; Fu X; Li Z; Qiu Y; Li W; Zhou Z; Xue W; Wang Y; Jin M; Zhang M
Biochem Biophys Res Commun; 2018 Oct; 504(2):525-531. PubMed ID: 30201265
[TBL] [Abstract][Full Text] [Related]
6. MTMR2 promotes the progression of NK/T cell lymphoma by targeting JAK1.
Wang J; He AL; Zhang WG; Cao XM; Chen YX; Liu J; Zhao WH; Yang Y; Wang JL; Liu HL; Ma XR
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8057-8066. PubMed ID: 32767332
[TBL] [Abstract][Full Text] [Related]
7. T-cell dysfunction in natural killer/T-cell lymphoma.
Feng X; Meng M; Li H; Gao Y; Song W; Di R; Li Z; Zhang X; Zhang M
Oncoimmunology; 2023; 12(1):2212532. PubMed ID: 37250921
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of sonic hedgehog signaling blocks cell migration and growth but induces apoptosis via suppression of FOXQ1 in natural killer/T-cell lymphoma.
Liu P; Chen L
Leuk Res; 2018 Jan; 64():1-9. PubMed ID: 29132010
[TBL] [Abstract][Full Text] [Related]
9. SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential.
Xiong J; Wang N; Zhong HJ; Cui BW; Cheng S; Sun R; Chen JY; Xu PP; Cai G; Wang L; Sun XJ; Huang JY; Zhao WL
EBioMedicine; 2021 Oct; 72():103614. PubMed ID: 34628354
[TBL] [Abstract][Full Text] [Related]
10. c-Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer/T-cell lymphoma.
Zhu L; Zhang X; Fu X; Li Z; Sun Z; Wu J; Wang X; Wang F; Li X; Niu S; Ding M; Yang Z; Yang W; Yin M; Zhang L; Zhang M
J Cell Biochem; 2019 Aug; 120(8):12628-12637. PubMed ID: 30825244
[TBL] [Abstract][Full Text] [Related]
11. Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma.
Chen YW; Guo T; Shen L; Wong KY; Tao Q; Choi WW; Au-Yeung RK; Chan YP; Wong ML; Tang JC; Liu WP; Li GD; Shimizu N; Loong F; Tse E; Kwong YL; Srivastava G
Blood; 2015 Mar; 125(10):1589-600. PubMed ID: 25612622
[TBL] [Abstract][Full Text] [Related]
12. IL-13 and IL-13Rα1 are overexpressed in extranodal natural killer/T cell lymphoma and mediate tumor cell proliferation.
Zhang Y; Li C; Zhang M; Li Z
Biochem Biophys Res Commun; 2018 Sep; 503(4):2715-2720. PubMed ID: 30107911
[TBL] [Abstract][Full Text] [Related]
13. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations.
Lin GW; Xu C; Chen K; Huang HQ; Chen J; Song B; Chan JKC; Li W; Liu W; Shih LY; Chuang WY; Kim WS; Tan W; Peng RJ; Laurensia Y; Cheah DMZ; Huang D; Cheng CL; Su YJ; Tan SY; Ng SB; Tang TPL; Han K; Wang VY; Jia WH; Pei Z; Li YJ; Gao S; Shi Y; Hu Z; Zhang F; Zhang B; Zeng YX; Shen H; He L; Ong CK; Lim ST; Chanock S; Kwong YL; Lin D; Rothman N; Khor CC; Lan Q; Bei JX;
Lancet Oncol; 2020 Feb; 21(2):306-316. PubMed ID: 31879220
[TBL] [Abstract][Full Text] [Related]
14. S100A9 Regulates MDSCs-Mediated Immune Suppression via the RAGE and TLR4 Signaling Pathways in Colorectal Carcinoma.
Huang M; Wu R; Chen L; Peng Q; Li S; Zhang Y; Zhou L; Duan L
Front Immunol; 2019; 10():2243. PubMed ID: 31620141
[TBL] [Abstract][Full Text] [Related]
15. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.
Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ
Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291
[TBL] [Abstract][Full Text] [Related]
16. Expression and significance of Ku80 and PDGFR-α in nasal NK/T-cell lymphoma.
Li J; Chen P; Liu W; Xia Z; Shi F; Zhong M
Pathol Res Pract; 2016 Mar; 212(3):204-9. PubMed ID: 26778387
[TBL] [Abstract][Full Text] [Related]
17. Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma.
Zhang XW; Bi XW; Liu PP; Liu ZL; Nie M; Yang H; Lei DX; Xia Y; Jiang WQ; Zeng WA
Front Oncol; 2020; 10():1360. PubMed ID: 32850435
[No Abstract] [Full Text] [Related]
18. HACE1, a potential tumor suppressor gene on 6q21, is not involved in extranodal natural killer/T-cell lymphoma pathophysiology.
Sako N; Dessirier V; Bagot M; Bensussan A; Schmitt C
Am J Pathol; 2014 Nov; 184(11):2899-907. PubMed ID: 25203537
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteomics of CSF reveals potential predicted biomarkers for extranodal NK-/T-cell lymphoma of nasal-type with ethmoidal sinus metastasis.
Gong Y; Pu W; Jin H; Yang P; Zeng H; Wang Y; Pang F; Ma X
Life Sci; 2018 Apr; 198():94-98. PubMed ID: 29496492
[TBL] [Abstract][Full Text] [Related]
20. MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1.
Chang Y; Cui M; Fu X; Zhang L; Li X; Li L; Wu J; Sun Z; Zhang X; Li Z; Nan F; Yan J; Zhang M
Cancer Biol Ther; 2019; 20(1):31-41. PubMed ID: 30299211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]